These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Use of menopausal hormones in the United States, 1992 through June, 2003. Wysowski DK, Governale LA. Pharmacoepidemiol Drug Saf; 2005 Mar 22; 14(3):171-6. PubMed ID: 15386701 [Abstract] [Full Text] [Related]
7. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women. Jirapinyo M, Theppisai U, Manonai J, Suchartwatnachai C, Jorgensen LN. Acta Obstet Gynecol Scand; 2003 Sep 22; 82(9):857-66. PubMed ID: 12911449 [Abstract] [Full Text] [Related]
8. "Add-back" therapy for endometriosis in adolescents. Lubianca JN, Gordon CM, Laufer MR. J Reprod Med; 1998 Mar 22; 43(3):164-72. PubMed ID: 9564639 [Abstract] [Full Text] [Related]
10. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia. Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M. Metabolism; 2009 Jan 22; 58(1):1-7. PubMed ID: 19059524 [Abstract] [Full Text] [Related]
11. Comparative cardiovascular effects of different progestins in menopause. Rosano GM, Fini M. Int J Fertil Womens Med; 2001 Jan 22; 46(5):248-56. PubMed ID: 11720197 [Abstract] [Full Text] [Related]
12. A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment. Lanfranco F, Zirilli L, Baldi M, Pignatti E, Corneli G, Ghigo E, Aimaretti G, Carani C, Rochira V. Bone; 2008 Sep 22; 43(3):628-35. PubMed ID: 18590994 [Abstract] [Full Text] [Related]
14. [Evaluation of the hematochemical parameters and bone mineral density of women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and surgical menopause treated with estrogen replacement. Part II]. Savoca S, D'Agosta S, Lombardo G. Minerva Ginecol; 2007 Jun 22; 59(3):215-22. PubMed ID: 17576400 [Abstract] [Full Text] [Related]
15. [Menstrual rhythm as functional expression of a central regulatory mechanism controlling the menstrual cycle in the female]. Schneider WH. Wien Klin Wochenschr; 1973 Jun 22; 85():Suppl 17:1-14. PubMed ID: 4690438 [No Abstract] [Full Text] [Related]
18. Cardiovascular risk markers during treatment with estradiol and trimegestone or dydrogesterone. Hellgren M, Conard J, Norris L, Kluft C. Maturitas; 2009 Mar 20; 62(3):287-93. PubMed ID: 19268506 [Abstract] [Full Text] [Related]